Egypt Anti-Fungal Market Expected to Grow Faster According to New Research Report 2023-2028

The Egypt Anti-Fungal Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Egypt Anti-Fungal market. This report explores all the key factors affecting the growth of the global Egypt Anti-Fungal market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141808/

Report Description of the Egypt Anti-Fungal Market

Research Scope and Assumption

The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off

Research Objective:

To analyze and forecast the market size of Egypt Anti-Fungal Drugs market
To classify and forecast Egypt Anti-Fungal Market Drugs market based on application, drugs, project type, and application.
To identify drivers and challenges for Egypt Anti-Fungal Drugs market
To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Egypt Anti-Fungal Drugs market
To conduct pricing analysis for Egypt Anti-Fungal Drugs market
To identify and analyze the profile of leading players operating in Egypt Anti-Fungal Drugs market

Reason to buy the report:

Facilitate decision-making based on strong current and forecast data for Anti-Fungal drug market
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Anti-Fungal market
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Egypt Anti-Fungal Market Executive Summary

Anti-fungal agents are used in the treatment of fungal infections. According to global action fund for fungal infection, globally, over 300 billion people of all ages suffer from a serious fungal infection every year. In next few years, the market of anti-fungal in middle east expected to grow enormously with growing population.

Market Size and Key Findings

The Middle East Anti-Fungal market size is at around USD 4.3 billion in 2020 and is projected to reach USD 1.08 billion in 2021, exhibiting a CAGR of 3.462% during the forecast period.

The middle east Anti- Fungal Market, in the next few years is expected to grow enormously with the growing global population. Increase in the prevalence of fungal infection has prompted to manufactures to develop advanced formulation medication for better clinical outcomes. This in turn is propelling the growth of the market during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad-spectrum antibiotics is a prime factor for the growing market for anti-fungal agents. Also, the rising population with a weak immune system, in whom fungal infections are much more than average, will drive the market. The high prevalence of conventional drugs used for the treatment of fungal infections is significantly restraining market growth.

Market Restraints

The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and generalization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. The market penetration is very easy as there has been loss of patents of blockbuster drugs. Over-the-counter drugs are an important reason for the growth of the anti-fungal agents market.

COVID-19 impact on "Egypt Anti-Fungal Market

29 billion in 2021 at a compound annual growth rate (CAGR) of 3.1%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $13.71 billion in 2025 at a CAGR of 7.4%

Competitive Landscape

Key Players

Some of the key players in this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others.

Products in Pipeline

While a new antifungal have been approved in decades, a number of drugs are undergoing clinical trials. These medicines in the pipeline involve new pathways or chemical modificationsto existing drugs. Their developers hope these inventions or modifications will help sidestep current problems with toxicity or fungal resistance. These new genertion therapy includes -Fosmanogepix, Olorfim,Ibexafungrep, Rezafungin, Oteseconazole and VT-1598.

Notable Recent Deals

Pfizer Inc. (NYSE: PFE) announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyxs lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections.

Healthcare Policies and Regulatory Landscape

Pricing and Reimbursement scenario of Anti-Fungal Drug

There is moderate concern among payers regarding spend on anti-Fungal drugs, but access restrictions remain mild. The expenditures related to the use of antifungal drugs per febrile neutropenic episode were $3,857.85 for VOR; $15,783.34 for caspofungin, and $21,561.02 for L-AmB, respectively. The expenditure related to the use of posaconazole (POS) was $32,167.39 per patient for primary or secondary prophylaxis. Currently, price-controlled antifungal drugs are less commonly used by practitioners. This shows the need to bridge the gap between policy makers and health-care service providers to help the ailing population.

To Know More About COVID-19 Impact On Egypt Anti-Fungal Market @ https://www.prudentmarkets.com/sample-request/141808/

Anti-Fungal Market Segmentation

Drug Type:

Based on the drug type, the market is segmented into azoles, echinocandins, polyenes, and allylamines. Azoles are considered to be the leading segment owing to its fungicidal properties and increased revenue generation in 2019. Azoles are systemic antifungal drugs that include fluconazole, and others which are highly recommended for fungal infection treatment, thereby upscaling the market.

Azoles
Echinocandins
Polyenes
Allylamines

By Indication:

In terms of indication, the market is segmented into dermatophytosis, aspergillosis, candidiasis, and others. Dermatophytosis is a non-fatal superficial infection on skin. Dermatophytosis is anticipated to dominate the market owing to an increase in prevalence of dermatophytosis cases.

Dermatophytosis
Aspergillosis
Candidiasis
Others

By Route of Administration:

In terms of route of administration, the market is segmented into oral, topical and parenteral. Among these, the topical antifungal route of administration holds the largest antifungal drugs market share owing to an increase in the adoption of topical drugs globally.

Oral
Topical
Parenteral

By Distribution Channel:

Based distribution channel, results regular hospital visits obtaining advanced for the pharmacies & also anticipated emerge as the fastest-growing segment the market. the rise the drug supply medical professionals, healthcare centers, and others. addition an increase the number patients for non-prescription drugs, and convenience drug, others are propelling the of pharmacies during the forecast period.

Hospitals and clinics
Retail Pharmacies and Drug stores
Online Pharmacies

By Application:

Based on the application Anti-Fungal Drug market has sub segmented into:

Ointments
Powder
Drugs
Pastes

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141808/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Egypt Anti-Fungal Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Egypt Anti-Fungal Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Egypt Anti-Fungal market
Chapter 2: Exclusive Summary - the basic information of the Egypt Anti-Fungal Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Egypt Anti-Fungal
Chapter 4: Presenting the Egypt Anti-Fungal Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Egypt Anti-Fungal market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141808/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Egypt Anti-Fungal Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.